Roche
Visit at https://www.roche.com
Roche
Roche is a Swiss multinational healthcare company pioneering in pharmaceuticals and diagnostics, committed to advancing science and improving patient lives through innovative treatments and technologies.
Positive signals
Roche achieved a Silver Medal from EcoVadis in 2025 with a score of 69/100, placing it in the top 15% of companies rated by EcoVadis over the previous 12 months.
Roche ranked 10th in the 2022 Access to Medicine Index, with a total score of 3.23, reflecting its efforts to improve access to essential medicines in low- and middle-income countries.
Roche has been recognized as one of the top three most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices (DJSI) for the fifteenth consecutive year as of December 2023.
Roche has maintained a leading position in the Dow Jones Sustainability Indices (DJSI) for 15 consecutive years, reflecting consistent high performance in economic, social, and environmental criteria.
Roche is committed to the Science Based Targets initiative (SBTi) to achieve net zero for scope 1, 2, and 3 greenhouse gas emissions, aligning its climate action with science-based targets.
Concerns
Legal action regarding trade secrets
HIGH
Source →Employee commitment and workplace culture
MEDIUM
Source →Sustainalytics rates Roche with a 'Medium' ESG risk, indicating that while Roche manages most material ESG issues well, there are still notable risks, particularly in product quality and safety, and business ethics.
MEDIUM
Source →
